Previsioni di mercato immunoistochimica per il Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per applicazione (diagnostica e test antidroga), prodotto (anticorpi, apparecchiature, reagenti e kit) e utente finale (ospedali e laboratori diagnostici, istituti di ricerca e altri) )

Introduzione al mercato

Il Nord America è il mercato più grande per l\'immunoistochimica e Stati Uniti, Canada e Messico sono i principali contributori al mercato in questa regione. Gli Stati Uniti hanno guidato il mercato durante il periodo di previsione. La crescita del mercato dell’immunoistochimica negli Stati Uniti è attribuita al rapido aumento dell’incidenza di malattie croniche come il cancro nel paese, nonché alla crescente domanda di strumenti diagnostici. L\'immunoistochimica (IHC) è una tecnica ampiamente utilizzata per la diagnosi del cancro; identifica selettivamente i marcatori tumorali nei tessuti biologici. Nel cancro al seno, l’immunoistochimica, ad esempio, quantifica il recettore degli estrogeni, il recettore del progesterone, il recettore-2 del fattore di crescita epidermico umano, Ki-67 e p53. Secondo la Breast Cancer Organization, nel 2019 verranno diagnosticati nelle donne degli Stati Uniti circa 268.600 nuovi casi di cancro al seno invasivo e circa 62.930 nuovi casi di cancro al seno non invasivo (in situ). Pertanto, man mano che il cancro al seno diventa più diffuso, è probabile che la richiesta di immunoistochimica aumenti. Inoltre, questa tecnica viene utilizzata per diagnosticare altri tipi di cancro, come il cancro alla prostata e il cancro ai polmoni. Secondo il National Cancer Institute, il paese vedrà 1.735.350 nuovi casi di cancro nel 2021. Cancro al seno, cancro ai polmoni e ai bronchi, cancro alla prostata, cancro al colon e al retto, cancro al melanoma e cancro al fegato sono i tipi più comuni di cancro. L’incidenza del cancro sta aumentando a un ritmo allarmante nel paese, con conseguente aumento della domanda di diagnosi di cancro. Crescente incidenza di malattie croniche e infettive e crescenti investimenti in ricerca e sviluppo da parte della biotecnologia e della ricerca. le aziende biofarmaceutiche sono il principale fattore che guida la crescita del mercato immunoistochimico del Nord America.

I paesi del Nord America, in particolare gli Stati Uniti, sono fortemente colpiti dall\'epidemia di COVID-19. Vari centri di ricerca sanitaria in tutto il paese si concentrano sui trattamenti COVID-19. L’epidemia pandemica ha influenzato negativamente le economie e le industrie di vari paesi a causa di blocchi, divieti di viaggio e chiusure di attività commerciali. La crisi del Covid-19 ha sovraccaricato i sistemi sanitari pubblici in molti paesi e ha evidenziato la forte necessità di investimenti sostenibili nei sistemi sanitari. Con il progredire della pandemia, si prevede che il settore sanitario registrerà un calo della crescita. Il segmento delle scienze della vita prospera grazie alla crescente domanda di prodotti diagnostici in vitro e alle crescenti attività di ricerca e sviluppo in Nord America. Tuttavia, il segmento delle tecnologie mediche e dell’imaging sta registrando un calo delle vendite a causa di un minor numero di interventi chirurgici eseguiti durante l’epidemia e di un approvvigionamento ritardato o prolungato di attrezzature. Inoltre, si prevede che le consultazioni virtuali da parte degli operatori sanitari diventeranno il modello tradizionale di erogazione delle cure post-pandemia. Con la telemedicina che sta trasformando l’erogazione delle cure, la sanità digitale continuerà a prosperare nei prossimi anni. Inoltre, si prevede che l’interruzione degli studi clinici e il conseguente ritardo nel lancio dei farmaci apriranno la strada a studi interamente virtuali in futuro. Si prevede che le nuove tecnologie, come l’mRNA, guideranno l’industria farmaceutica. Pertanto, si prevede che il mercato sarà testimone di integrazioni verticali e joint venture nei prossimi anni.

Panoramica e dinamiche del mercato

Il mercato Si prevede che il mercato immunoistochimico del Nord America crescerà da 838,05 milioni di dollari nel 2021 a 1.405,86 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,7% dal 2021 al 2028. I mercati emergenti in tutta la regione stanno creando significative opportunità per i principali attori del mercato di espandere la propria attività. È probabile che sarà un fattore primario che contribuirà alla crescita del mercato nei prossimi anni. La maggior parte degli operatori si concentra sui mercati in via di sviluppo, a causa della vasta popolazione che soffre di malattie croniche nella regione. Con l’aumento dei costi di produzione rispetto alle loro pratiche, le aziende sanitarie stanno cercando di produrre entrate sufficienti per intrattenere i propri investitori. Si prevede che i mercati in alcune economie in crescita costituiranno una parte essenziale per offrire opportunità di crescita più affidabili e redditizie affinché i principali attori possano espandere la propria portata industriale. I progressi nel campo della biotecnologia hanno aumentato la domanda di strumenti diagnostici nel mercato sanitario, incoraggiando l’introduzione di un numero più significativo di sistemi di test immunologici e facilitando il passaggio alla medicina personalizzata. Nei paesi emergenti si aprono nuove opportunità nei test sulle malattie infettive, nell’oncologia molecolare e nella farmacogenomica. Pertanto, le aziende sanitarie possono rivolgersi ai pazienti o ai consumatori della regione. Negli anni precedenti si è registrato un aumento della spesa sanitaria dei paesi. Vari attori del settore hanno investito una parte significativa dei propri ricavi in attività di ricerca e sviluppo per lo sviluppo di prodotti e tecnologie migliori e avanzati da utilizzare nel settore sanitario. La presenza di importanti aziende biofarmaceutiche nella regione e il numero crescente di aziende locali sono i fattori che contribuiscono alla crescita del mercato nella regione. Queste attività nella regione stanno aumentando la domanda di immunoistochimica. Pertanto, il crescente numero di casi di malattie infettive e i progressi nei paesi emergenti probabilmente daranno impulso al mercato e si prevede che forniranno significative opportunità di crescita agli attori che operano nel mercato del Nord America durante il periodo di previsione.

< strong>Segmenti chiave del mercato

In termini di prodotto, il segmento degli anticorpi ha rappresentato la quota maggiore del mercato immunoistochimico del Nord America nel 2020. In termini di applicazione, nel 2020, il segmento della diagnostica ha detenuto una quota di mercato maggiore del mercato dell\'immunoistochimica del Nord America. Inoltre, nel 2020, il segmento degli ospedali e dei laboratori diagnostici ha detenuto una quota maggiore del mercato dell\'immunoistochimica del Nord America in base all\'utente finale.

Principali fonti e società elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato immunoistochimico del Nord America sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali società elencate nel rapporto sono Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORI INC.; Tecnologia di segnalazione cellulare, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; e THERMO FISHER SCIENTIFIC INC.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato immunoistochimico del Nord America e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte ritorno
Mantenere un vantaggio comprendendo le sempre più cambiamento del panorama competitivo per il mercato immunoistochimico del Nord America
Pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership nel mercato immunoistochimico del Nord America identificando segmenti di mercato con le vendite probabili più promettenti
Aiuta a intraprendere affari consapevoli decisioni derivanti da un\'analisi percettiva e completa delle prestazioni di mercato di vari segmenti del mercato immunoistochimico del Nord America
Ottenere previsioni sulle entrate di mercato per il mercato in base a vari segmenti dal 2021-2028 nella regione del Nord America.

Segmentazione del mercato immunoistochimico del Nord America
Mercato immunoistochimico del Nord America - per prodotto

Attrezzature
- Sistemi di colorazione dei vetrini
- Sistemi di microarray per tessuti
- Sistemi di lavorazione dei tessuti
- Scanner per vetrini
- Altre apparecchiature
Anticorpi
- Anticorpi primari
- Anticorpi secondari
Reagenti
- Coloranti istologici
- Reagenti di bloccaggio e fissazione
- Substrati cromogenici
- Reagenti di fissazione
- Stabilizzanti
- Solventi organici
- Enzimi proteolitici
- Diluenti
Kit

Mercato immunoistochimico del Nord America - per applicazione

Diagnostica
- Cancro
- Malattie infettive
- Malattie autoimmuni
- Diabete mellito
- Malattie nefrologiche
- Altri
Test antidroga

Mercato immunoistochimico del Nord America - Per utente finale

Ospedali e laboratori diagnostici
Istituti di ricerca
Altri

Mercato immunoistochimico del Nord America - Per paese

Stati Uniti
Canada
Messico

Mercato immunoistochimico del Nord America - Profili aziendali

Abcam plc
Agilent Technologies, Inc.
Bio SB
BIO-RAD LABORATORIES INC.
Tecnologia di segnalazione cellulare, Inc.
Danaher
F. HOFFMANN-LA ROCHE LTD.
MERCK KGaA
PerkinElmer Inc.
THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Immunohistochemistry Market – By Product

1.3.2 North America Immunohistochemistry Market – By Application

1.3.3 North America Immunohistochemistry Market – By End User

1.3.4 North America Immunohistochemistry Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Immunohistochemistry Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Immunohistochemistry Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Incidences of Chronic and Infectious Diseases

5.1.2 Rising R&D Investments by Biotechnology & Biopharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Complexities Associated with Immunohistochemistry

5.3 Key Market Opportunities

5.3.1 Growth Opportunities in Several Countries

5.4 Future Trends

5.4.1 Rise of Automation in Immunohistochemistry

5.5 Impact Analysis

6. Immunohistochemistry Market – North America Analysis

6.1 North America Immunohistochemistry Market Revenue Forecast and Analysis

7. North America Immunohistochemistry Market Analysis– By Product

7.1 Overview

7.2 North America Immunohistochemistry Market, By Product 2021 & 2028 (%)

7.3 Antibodies

7.3.1 Overview

7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.3 Primary Antibodies

7.3.3.1 Overview

7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.4 Secondary Antibodies

7.3.4.1 Overview

7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Equipment Market

7.4.1 Overview

7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3 Slide Staining Systems

7.4.3.1 Overview

7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4 Tissue Microarrays

7.4.4.1 Overview

7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5 Tissue Processing Systems

7.4.5.1 Overview

7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6 Slide Scanners

7.4.6.1 Overview

7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7 Other Equipments

7.4.7.1 Overview

7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Reagents Market

7.5.1 Overview

7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.3 Histological Stains

7.5.3.1 Overview

7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.4 Blocking Sera & Reagents Market

7.5.4.1 Overview

7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.5 Chromogenic Substrates Market

7.5.5.1 Overview

7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.6 Stabilizers

7.5.6.1 Overview

7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.7 Proteolytic Enzymes

7.5.7.1 Overview

7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.8 Organic Solvents

7.5.8.1 Overview

7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.9 Fixation Reagents

7.5.9.1 Overview

7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.5.10 Diluents

7.5.10.1 Overview

7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

7.6 Kits Market

7.6.1 Overview

7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

8. North America Immunohistochemistry Market Analysis – By Application

8.1 Overview

8.2 North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

8.3 Diagnostics

8.3.1 Overview

8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

8.3.3 Cancer

8.3.3.1 Overview

8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)

8.3.4 Infectious Diseases

8.3.4.1 Overview

8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.5 Autoimmune Diseases

8.3.5.1 Overview

8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.6 Diabetes Mellitus

8.3.6.1 Overview

8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)

8.3.7 Nephrological Diseases

8.3.7.1 Overview

8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.3.8 Others

8.3.8.1 Overview

8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Drug Testing

8.4.1 Overview

8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Global Immunohistochemistry Market Analysis– By End User

9.1 Overview

9.2 North America Immunohistochemistry Market, By End User 2021 & 2028 (%)

9.3 Hospital & Diagnostic Laboratories

9.3.1 Overview

9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Research Institutes

9.4.1 Overview

9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Others

9.5.1 Overview

9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10. North America Immunohistochemistry Market – Country Analysis

10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028

10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)

10.1.1.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

10.1.1.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

10.1.1.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)

10.1.1.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

10.1.1.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)

10.1.1.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)

10.1.1.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

11. Impact Of COVID-19 Pandemic on North America Immunohistochemistry Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic developments

12.3.1 Overview

13. Company Profiles

13.1 Cell Signaling Technology, Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 F. HOFFMANN-LA ROCHE LTD.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 MERCK KGaA

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 PerkinElmer Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Abcam plc

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Agilent Technologies, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 BIO-RAD LABORATORIES INC.

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Danaher

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Bio SB

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)

Table 2. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 3. US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 4. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 5. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 6. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 7. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 8. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 9. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 10. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 11. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 12. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)

Table 13. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 14. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 15. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 16. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)

Table 17. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)

Table 18. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)

Table 19. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)

Table 20. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)

Table 21. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)

Table 22. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)

Table 23. Organic Developments Done By Companies

Table 24. Inorganic developments done by Companies

Table 25. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Immunohistochemistry Market Segmentation

Figure 2. North America Immunohistochemistry Market Segmentation, By Country

Figure 3. North America Immunohistochemistry Market Overview

Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America PEST Analysis

Figure 7. Impact Analysis of Drivers and Restraints Pertaining to North America Immunohistochemistry Market

Figure 8. North America Immunohistochemistry Market – Revenue Forecast and Analysis

Figure 9. North America Immunohistochemistry Market, by Product 2021 & 2028 (%)

Figure 10. North America Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. North America Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. North America Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. North America Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. North America Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. North America Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. North America Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. North America Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. North America Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. North America Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. North America Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. North America Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. North America Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. North America Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. North America Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. North America Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. North America Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. North America Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. North America Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)

Figure 30. North America Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 31. North America Cancer Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 32. North America Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 33. North America Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 34. North America Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 35. North America Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 36. North America Others Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 37. North America Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 38. North America Immunohistochemistry Market, by End User 2021 & 2028 (%)

Figure 39. North America Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40. North America Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. North America Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)

Figure 43. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)

Figure 44. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 45. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 46. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 47. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample